赛伦生物
(688163)
| 流通市值：8.63亿 | | | 总市值：21.05亿 |
| 流通股本：4437.20万 | | | 总股本：1.08亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 25,621,279.55 | 194,915,924.94 | 173,291,573.09 | 98,058,273.88 |
| 营业收入 | 25,621,279.55 | 194,915,924.94 | 173,291,573.09 | 98,058,273.88 |
| 二、营业总成本 | 23,621,291.88 | 143,439,085.68 | 107,900,485.01 | 68,030,894.07 |
| 营业成本 | 6,449,803.93 | 42,770,555.87 | 36,680,661.47 | 22,982,176.35 |
| 税金及附加 | 368,076.83 | 1,795,252.05 | 1,313,239.82 | 796,694.64 |
| 销售费用 | 9,087,859.92 | 54,520,612.25 | 39,321,198.92 | 22,278,261.72 |
| 管理费用 | 4,935,368.47 | 22,186,727.9 | 15,836,303 | 10,494,656.68 |
| 研发费用 | 3,182,878.72 | 23,839,957.85 | 16,170,774.43 | 12,398,153.48 |
| 财务费用 | -402,695.99 | -1,674,020.24 | -1,421,692.63 | -919,048.8 |
| 其中:利息费用 | 42,018.06 | 430,189 | 354,998.31 | 311,586.54 |
| 其中:利息收入 | -448,795.13 | 2,161,838.76 | 1,802,954.85 | 1,222,685.5 |
| 加:公允价值变动收益 | 1,001,068.49 | 1,207,523.29 | 1,503,178.08 | 1,974,950.68 |
| 加:投资收益 | 2,266,175.69 | 3,961,651.43 | 7,953,077.91 | 4,355,471.46 |
| 资产处置收益 | - | 1,446,155.63 | 1,440,483.79 | - |
| 资产减值损失(新) | -461,598.53 | -9,209,017.29 | -3,940,038.25 | -907,985.82 |
| 信用减值损失(新) | -661,213.96 | -485,439.3 | -1,610,343.77 | -1,666,319.51 |
| 其他收益 | 85,021.05 | 3,587,234.77 | 3,549,290.77 | 3,449,290.77 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 4,229,440.41 | 51,984,947.79 | 74,286,736.61 | 37,232,787.39 |
| 加:营业外收入 | 90,409.71 | 5,463.01 | 9,834.85 | 1,063.01 |
| 减:营业外支出 | 151,951.06 | 1,424,357.61 | 665,119.68 | 179,140.04 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 4,167,899.06 | 50,566,053.19 | 73,631,451.78 | 37,054,710.36 |
| 减:所得税费用 | 410,582.84 | 6,275,649.91 | 10,683,911.03 | 4,746,898.1 |
| 六、净利润 | 3,757,316.22 | 44,290,403.28 | 62,947,540.75 | 32,307,812.26 |
| 持续经营净利润 | 3,757,316.22 | 44,290,403.28 | 62,947,540.75 | 32,307,812.26 |
| 归属于母公司股东的净利润 | 3,757,316.22 | 44,290,403.28 | 62,947,540.75 | 32,307,812.26 |
| (一)基本每股收益 | 0.03 | 0.41 | 0.58 | 0.3 |
| (二)稀释每股收益 | 0.03 | 0.41 | 0.58 | 0.3 |
| 九、综合收益总额 | 3,757,316.22 | 44,290,403.28 | 62,947,540.75 | 32,307,812.26 |
| 归属于母公司股东的综合收益总额 | 3,757,316.22 | 44,290,403.28 | 62,947,540.75 | 32,307,812.26 |
| 归属于少数股东的综合收益总额 | - | - | 0 | - |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-26 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |